Came across this article, I don't think its a repost (?) It was published last Nov 28, 2018. Just last week, the University of Washington, School of Medicine and Pascal Biosciences, Inc. (TSX.V: PAS) announced a joint licensing agreement which hopes to receive FDA approval for a cannabinoid-based cancer treatment as early as next year. With help from CoMotion, UW’s collaborative innovation hub, to negotiate the deal between UW and Pascal, the agreement allows for research with commercial development milestones and covers ST-403 and all related compounds. More about this from Dr. Stella's lab found here.